Recent Advances in Colorectal Cancer Research
Colorectal cancer is the second leading cause of cancer death in the United States. More than 50,000 people are...
Colorectal cancer is the second leading cause of cancer death in the United States. More than 50,000 people are...
A session at the AACR Annual Meeting 2024 offered advice on better ways to communicate science to the public....
The COVID-19 pandemic has taken a devastating toll, with 5.8 million deaths worldwide, including nearly 1 million in the...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
Cancer researchers and cancer survivors are often viewed in separate silos. Scientists toil away alone in laboratories to decode the mechanisms of the disease and test novel molecules. Cancer...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...
Ten years ago, then-President of the AACR, Tyler Jacks, PhD, FAACR, conceived the idea for a “comprehensive, high-impact journal that would present new...
As we welcome the fall season, it’s time for our September edition of Editors’ Picks, a monthly collection of...
Recent advances in cancer research has led to enormous progress against many cancer types. From 1991 to 2015, we...
As we head into summer, enjoy this month’s selection of studies spotlighted by the editors of the 10 AACR...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
Cancer Today empowers readers to be active and involved in their treatment and survivor experiences.
As the candy supply dwindles, and the Halloween sugar rush tapers off, get re-energized by the latest edition of...
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
You’re feeling sluggish. You eat a banana. You feel better. We all know that a calorie-rich snack can provide...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
Lesbian, gay, bisexual, and transgender (LGBT) people may be at increased risk of certain cancers.
A young adult shares his story of leaving college and learning to rely on his mother as he battled...
The story is familiar: A patient is diagnosed with cancer, they begin treatment, and, after a few months, they...
Sara Hanna Velarde, PhD, began her career in cancer research as a graduate student at the University of North...
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
For October’s installment of Editors’ Picks, the AACR journal editors have selected studies that feature results from two phase...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
For the month of June, the editors of the nine AACR journals highlighted results from two clinical trials, preclinical data on KRAS inhibitors...
Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI)...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
The relationship between cigarette smoking and lung cancer was first brought to the public’s attention more than 50 years...